Aimei Health Technology (AFJK) Competitors $11.00 +0.03 (+0.27%) As of 04/17/2025 02:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AFJK vs. CEPO, SBXD, RENE, TCI, SJT, PUYI, NREF, PINE, OACC, and UROYShould you be buying Aimei Health Technology stock or one of its competitors? The main competitors of Aimei Health Technology include Cantor Equity Partners I (CEPO), Silverbox Corp IV (SBXD), Cartesian Growth Co. II (RENE), Transcontinental Realty Investors (TCI), San Juan Basin Royalty Trust (SJT), Highest Performances (PUYI), NexPoint Real Estate Finance (NREF), Alpine Income Property Trust (PINE), Oaktree Acquisition Corp. III Life Sciences (OACC), and Uranium Royalty (UROY). These companies are all part of the "trading" industry. Aimei Health Technology vs. Cantor Equity Partners I Silverbox Corp IV Cartesian Growth Co. II Transcontinental Realty Investors San Juan Basin Royalty Trust Highest Performances NexPoint Real Estate Finance Alpine Income Property Trust Oaktree Acquisition Corp. III Life Sciences Uranium Royalty Aimei Health Technology (NASDAQ:AFJK) and Cantor Equity Partners I (NASDAQ:CEPO) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, community ranking, media sentiment, profitability, dividends, risk and institutional ownership. Does the media refer more to AFJK or CEPO? In the previous week, Aimei Health Technology's average media sentiment score of 0.00 equaled Cantor Equity Partners I'saverage media sentiment score. Company Overall Sentiment Aimei Health Technology Neutral Cantor Equity Partners I Neutral Is AFJK or CEPO more profitable? Company Net Margins Return on Equity Return on Assets Aimei Health TechnologyN/A N/A N/A Cantor Equity Partners I N/A N/A N/A Does the MarketBeat Community favor AFJK or CEPO? Aimei Health Technology and Cantor Equity Partners I both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAimei Health TechnologyN/AN/ACantor Equity Partners IN/AN/A Do insiders and institutionals have more ownership in AFJK or CEPO? 45.6% of Aimei Health Technology shares are owned by institutional investors. 1.7% of Aimei Health Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, AFJK or CEPO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAimei Health TechnologyN/AN/A$170KN/AN/ACantor Equity Partners IN/AN/AN/AN/AN/A SummaryAimei Health Technology beats Cantor Equity Partners I on 2 of the 2 factors compared between the two stocks. Get Aimei Health Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for AFJK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFJK vs. The Competition Export to ExcelMetricAimei Health TechnologyHolding Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$67.34M$454.89M$3.66B$7.34BDividend YieldN/A8.15%4.20%4.30%P/E RatioN/A2.3814.0117.78Price / SalesN/A59.121,657.5497.74Price / Cash500.2069.0150.1934.64Price / Book-550.003.663.333.97Net Income$170,000.00$35.22M$1.23B$247.65M7 Day Performance-0.04%2.89%2.02%1.80%1 Month Performance0.64%0.13%0.10%-6.98%1 Year Performance7.11%19.83%9.94%1.34% Aimei Health Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFJKAimei Health TechnologyN/A$11.00+0.3%N/AN/A$67.34MN/A0.00N/ANews CoverageCEPOCantor Equity Partners IN/A$10.38+0.3%N/AN/A$264.69MN/A0.002Positive NewsSBXDSilverbox Corp IVN/A$10.20-0.1%N/AN/A$259.64MN/A0.00N/AHigh Trading VolumeRENECartesian Growth Co. IIN/A$11.92flatN/A+6.7%$257.72MN/A0.002Positive NewsHigh Trading VolumeTCITranscontinental Realty Investors0.862 of 5 stars$28.43-0.1%N/A-11.8%$245.61M$44.76M76.84N/ASJTSan Juan Basin Royalty Trust1.3419 of 5 stars$5.24+1.9%N/A+23.6%$244.23M$6.95M19.412,020News CoveragePUYIHighest PerformancesN/A$4.00-2.4%N/A-42.2%$240.98M$114.44M0.00550Gap UpNREFNexPoint Real Estate Finance3.5244 of 5 stars$13.51+0.8%$14.50+7.3%+7.0%$238.37M$29.20M12.871Positive NewsPINEAlpine Income Property Trust2.7785 of 5 stars$16.16+1.5%$19.14+18.4%+13.1%$233.93M$52.23M115.43N/AUpcoming EarningsShort Interest ↑Positive NewsOACCOaktree Acquisition Corp. III Life SciencesN/A$10.17+0.3%N/AN/A$228.06MN/A0.00N/APositive NewsUROYUranium Royalty1.3089 of 5 stars$1.67-0.9%$5.60+236.3%-23.1%$222.50M$23.14M55.5210Positive News Related Companies and Tools Related Companies CEPO Competitors SBXD Competitors RENE Competitors TCI Competitors SJT Competitors PUYI Competitors NREF Competitors PINE Competitors OACC Competitors UROY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFJK) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aimei Health Technology Co., Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Aimei Health Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.